Frontiers in Cellular and Infection Microbiology · 2024 · 10 citations · 28 references
MedicineImmunologyInfectious DiseasesInflammationInnate ImmunityOcular ImmunologyCorneal ImmunologyCorneal InfectionImmunopathology Of The EyeMacrophage BiologyOcular InflammationViral Eye InfectionsCorneal MacrophagesHerpes Simplex KeratitisInnate Immune EffectorsInnate Immune FunctionMacrophage Inflammatory ResponsesNlrp12 RegulationOcular Herpes Simplex Virus InfectionPyroptosis Mechanisms
Introduction: Herpes simplex keratitis (HSK) is a blinding disease caused by corneal infection of Herpes simplex virus type 1 (HSV-1). Effective clearance of HSV-1 from the infected cornea is crucial for HSK management. Macrophages play an important part in the innate immune defense against viral infections. This study investigates the immunomodulatory role of NLRP12 in macrophage immune response during HSV-1 infection. Methods: studies, ocular adoptive transfer of NLRP12-overexpressing bone marrow derived macrophages (BMDMs) was performed. HSV-1 viral loads, HSK symptoms, and macrophage-mediated immune responses were investigated. Results: A significant decrease in NLRP12 expression post-infection was observed in various macrophage cell lines. Overexpression of NLRP12 in macrophages reduced HSV-1 replication. Mechanistically, overexpression of NLRP12 triggered early and robust pyroptosis in response to HSV-1 infection, inducing interleukin (IL)-18 production and activating downstream antiviral responses through the JAK-STAT signaling pathway. In vivo, ocular adoptive transfer of NLRP12-overexpressing BMDMs to mouse corneas alleviated HSK damage and reduced HSV-1 viral loads. NLRP12-overexpressing BMDMs improved antiviral responses in the cornea and promoted the maturation of corneal-infiltrating macrophages and dendritic cells. Additionally, NLRP12-overexpressing BMDMs amplified the adaptive immune response in the submandibular draining lymph nodes. Discussion: These findings highlight the role of NLRP12 in macrophage-mediated immune response against HSV-1 infection and suggest its potential for possible immunotherapy for HSK.
28
The NLRP12 Inflammasome Recognizes Yersinia pestis
Gregory I. Vladimer, Dan Weng, Sara W. Montminy Paquette et al. · Immunity · 2012 · 362 citations · Full text